Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction. A Case Control Study

NCT00859300 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT00859300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00859300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction. A Case Control Study
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
December 31, 2007
Completion date
June 30, 2015
Enrollment
1,011 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction